The metabolic syndrome and nonfatal ischemic heart disease; a population-based study

Ford, 2004, Increasing prevalence of the metabolic syndrome among U.S. adults, Diabetes Care, 27, 2444, 10.2337/diacare.27.10.2444 Liese, 1998, Development of the multiple metabolic syndrome: an epidemiologic perspective, Epidemiol Rev, 20, 157, 10.1093/oxfordjournals.epirev.a017978 Grundy, 2002, Obesity, metabolic syndrome, and coronary atherosclerosis, Circulation, 105, 2696, 10.1161/01.CIR.0000020650.86137.84 Malik, 2004, Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults, Circulation, 110, 1245, 10.1161/01.CIR.0000140677.20606.0E Vitarius, 2005, The metabolic syndrome and cardiovascular disease, Mt Sinai J med, 72, 257 Pasqui, 2005, Structural and functional abnormality of systemic microvessels in cardiac syndrome X, Nutr Metab Cardiovasc Dis, 15, 56, 10.1016/j.numecd.2004.05.001 Turhan, 2005, Impaired coronary collateral vessel development in patients with metabolic syndrome, Coron Artery Dis, 16, 281, 10.1097/00019501-200508000-00004 Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709 Ford, 2004, The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study, Atherosclerosis, 173, 309, 10.1016/j.atherosclerosis.2003.12.022 Hunt, 2004, San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study, Circulation, 110, 1251, 10.1161/01.CIR.0000140762.04598.F9 Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 Resnick, 2003, Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study, Diabetes Care, 26, 861, 10.2337/diacare.26.3.861 Rutter, 2004, C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study, Circulation, 110, 380, 10.1161/01.CIR.0000136581.59584.0E Mc Neili, 2005, The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study, Diabetes Care, 28, 385, 10.2337/diacare.28.2.385 Lindblad, 2001, Metabolic syndrome and ischemic heart disease in elderly men and women, Am J Epidemiol, 153, 481, 10.1093/aje/153.5.481 Bonora, 2003, Carotid atherosclerosis and coronary heart disease in the metabolic syndrome, Diabetes Care, 26, 1251, 10.2337/diacare.26.4.1251 Cerniauskiene, 2005, Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population, Medicina, 41, 435 WHO MONICA Project. MONICA manual, 1999 (http://www.ktl.fi/publications/monica/manual/index.htm). 2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486 Prineas, 1982 Choudhury, 1996, Association between electrocardiographic ischemic abnormalities and ischemic heart disease risk factors in a Japanese population, J Hum Hypertens, 10, 225 Sattar, 2003, Metabolic syndrome with and without C-reactive protein as a predictor of heart disease and diabetes in the West of Scotland Coronary Prevention Study, Circulation, 108, 414, 10.1161/01.CIR.0000080897.52664.94 Macfarlane, 2004, Looking for prognostic information in the ST-T segment. Is it really worth it?, J Electrocardiol, 37, 209, 10.1016/j.jelectrocard.2004.08.059 De Bacquer, 1998, Prognostic value of ECK findings for total, cardiovascular disease, and heart disease death in men and women, Heart, 80, 570, 10.1136/hrt.80.6.570 Sarrf-Zadegan, 1999, The prevalence of coronary artery disease in an urban population in Isfahan, Iran, Acta Cardiol, 54, 257 De Bacquer, 1998, Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women, J Am Coll Cardiol, 32, 680, 10.1016/S0735-1097(98)00303-9 Macfarlane, 2000, Minnesota coding and the prevalence of ECG abnormalities, Heart, 84, 582, 10.1136/heart.84.6.582 Cameron, 2004, The metabolic syndrome: prevalence in worldwide population, Endocrinol Metab Clin N Am, 33, 351, 10.1016/j.ecl.2004.03.005 Azizi, 2003, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study, Diabetes Res Clin Pract, 61, 29, 10.1016/S0168-8227(03)00066-4 Natali, 2004, Hypertension, insulin resistance, and the metabolic syndrome, Endocrinol Metab Clin N Am, 33, 417, 10.1016/j.ecl.2004.03.007 Wong, 2003, Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome, Am J Cardiol, 91, 1421, 10.1016/S0002-9149(03)00392-8 Sorrentino, 2005, Implications of the metabolic syndrome: the new epidemic, Am J Cardiol, 96, 3E, 10.1016/j.amjcard.2005.05.008